Stayble Therapeutics AB (publ) (STABL.ST)

SEK 0.39

(1.56%)

Annual Income Statements

(In SEK)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - - 537.89 40.11 Thousand
Cost of Revenue - - - - - -
Gross Profit - - - - 537.89 40.11 Thousand
Operating Expenses 23.95 Million 24.95 Million 12.14 Million 14.98 Million 6.87 Million 6.11 Million
Selling, General and Administrative Expenses 24 Million 24.95 Million 9.14 Million 13.68 Million 6.07 Million 4.82 Million
Research and Development Expenses - - - - - -
Other Expenses -47.97 Thousand 24.95 Million 2.99 Million 1.29 Million 797.51 Thousand 1.29 Million
Cost and Expenses 23.95 Million 24.95 Million 12.14 Million 14.98 Million 6.87 Million 6.11 Million
Operating Income -23.95 Million -24.79 Million -12.13 Million -14.92 Million -6.87 Million -6.11 Million
Interest Expense - 27.94 Thousand 57.09 Thousand 396.16 Thousand 534.87 Thousand 14.8 Thousand
Income Tax Expense - -298.44 Thousand -49.52 Thousand 562.34 Thousand 533.34 Thousand -161.14 Thousand
Earnings before Tax -23.73 Million -24.52 Million -12.09 Million -15.48 Million -7.4 Million -6.13 Million
Net Income -23.73 Million -24.22 Million -12.04 Million -16.04 Million -7.94 Million -6.13 Million
Earnings Per Share Basic -0.92 -1.70 -0.85 -1.80 -0.63 -0.69
Earnings Per Share Diluted -0.92 -1.70 -0.85 -1.80 -0.63 -0.69
Weighted Average Shares Outstanding 25.76 Million 14.22 Million 14.22 Million 8.91 Million 12.59 Million 8.91 Million
Weighted Average Shares Outstanding (Diluted) 25.76 Million 14.22 Million 14.22 Million 8.91 Million 12.59 Million 8.91 Million
Gross Margin - - - - 1.00 1.00
EBIT Margin - - - - -12.77 Thousand -152.57
Profit Margin - - - - -14.76 Thousand -152.94
EBITDA 309.41 Thousand - - - - -2676.00
Earnings Before Tax Margin - - - - -12.78 Thousand -152.57

Income Statement Charts